Home > Cashflow Statement > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
Cashflow Statement

SYNCOM FORMULATIONS (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

SYNCOM FORMULATIONS (INDIA) Last 5 Year Cashflow Statement History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2017
Profit Before Tax₹66 Cr₹34 Cr₹27 Cr₹26 Cr₹16 Cr
Adjustment ₹-11 Cr₹-3.48 Cr₹-6.11 Cr₹-7.16 Cr₹0.71 Cr
Changes In working Capital ₹-16 Cr₹-28 Cr₹-3.26 Cr₹3.58 Cr₹1.29 Cr
Cash Flow after changes in Working Capital ₹38 Cr₹2.13 Cr₹17 Cr₹23 Cr₹18 Cr
Cash Flow from Operating Activities ₹23 Cr₹-5.96 Cr₹11 Cr₹16 Cr₹14 Cr
Cash Flow from Investing Activities ₹-18 Cr₹83 Cr₹-45 Cr₹-27 Cr₹-18 Cr
Cash Flow from Financing Activities ₹-68 Cr₹-15 Cr₹35 Cr₹8.29 Cr₹4.67 Cr
Net Cash Inflow / Outflow ₹-63 Cr₹63 Cr₹0.58 Cr₹-2.45 Cr₹0.83 Cr
Opening Cash & Cash Equivalents ₹63 Cr₹0.88 Cr₹0.30 Cr₹2.75 Cr₹5.69 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger -----
Cash & Cash Equivalent of Subsidiaries under liquidations -----
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations -----
Closing Cash & Cash Equivalent ₹0.71 Cr₹63 Cr₹0.88 Cr₹0.30 Cr₹6.52 Cr

Compare Cashflow Statement of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹968.2 Cr -8.4% -19.2% -40% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹421,647.0 Cr 0.1% -0.4% 0.6% Stock Analytics
DIVIS LABORATORIES ₹157,862.0 Cr -1.1% -7.1% 1.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹142,846.0 Cr 0.2% -4.5% 30.9% Stock Analytics
DR REDDYS LABORATORIES ₹104,720.0 Cr 0.2% -4% 6% Stock Analytics
CIPLA ₹98,795.9 Cr 0% -9.1% -18.5% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

-8.4%

-19.2%

-40%

SENSEX

-3.5%

-12.5%

-6.5%


You may also like the below Video Courses